Open-label, concomitant use of lamotrigine and other medications for bipolar disorder

CNS Spectrums

Volumn 13, Issue 1, 2008, Pages 75-83

  Bowden, Charles L ^a,c   Edwards, Suzanne ^b   Evoniuk, Gary ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIARRHEA; DIZZINESS; DRUG DOSE ESCALATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; NAUSEA; OPEN STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 38949141969     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900016187     Document Type: Article

References (23)

1. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293-299.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DMS-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
3. Keck PE, McElroy SL, Arnold LM. Bipolar disorder. Med Clin North Am. 2001;85:645-661.
4. Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry. 2000;61(suppl 13):19-25.
5. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry. 1998;155:12-21.
6. Bowden CL. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother. 2002;3:1513-1519.
7. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003;60:392-400.
8. Calabrese J, Bowden C, Sachs G, et al. A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003;64:1013-1024.
9. Calabrese JR, Vieta E, Shelton MD. Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol. 2003;13(suppl 2):S57-S66.
10. Pies R. Combining lithium and anticonvulsants in bipolar disorder: a review. Ann Clin Psychiatry. 2002;14:223-232.
11. Zarate CA Jr, Quiroz JA. Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disord. 2003;5:217-225.
12. Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry. 2003;64(suppl 5):18-24.
13. Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature. J Clin Psychiatry. 2002;63:146-151.
14. Messenheimer J, Mullens EL, Giorgi L, Young F. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 1998;18:281-296.
15. Lamictal [package insert], Middlesex, UK: GlaxoSmithKline; 2005.
16. Bowden CL. Valproate. Bipolar Disord. 2003;5:189-202.
17. McIntyre RS, Konarski JZ. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry. 2005;66(suppl 3):28-36.
18. Calabrese JR, Rapport DJ, Kimmel SE, et al. Controlled trials in bipolar I depression: Focus on switch rates and efficacy. Eur Neuropsychopharmacol. 1999;9(suppl 4):S109-S112.
19. Howland RH. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol. 1996;16:425-427.
20. Compton MT, Nemeroff CB. The treatment of bipolar depression. J Clin Psychiatry. 2000;61(suppl 9):57-67.
21. Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry. 1994;164:549-550.
22. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57:481-489.
23. Tohen M, Chengappa KNR, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59:62-69.